 The purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimers disease. The anti-oxidant treatments include vitamin E C alpha-lipoic acid, and Coenzyme Q CoQ. 